Search Results
The role of non-antibody-based approaches to immunomodulation in multiple myeloma
The Evolving Role of Immune Therapies in Multiple Myeloma
Novel immunotherapies for the treatment of multiple myeloma
Immunomodulation of NK cells for the treatment of lymphoid malignancies
Treating High Risk Multiple Myeloma an Evidence-Based Approach | Katja Weisel, MD | IMS 2024
2019 Multiple Myeloma Symposium | Novel and Next Generation Therapy
Current and emerging novel immunotherapies for myeloma
The rationale for protein degradation and immunomodulation in RRMM: Latest data and clinical trials
Optimising the management of multiple myeloma in the early relapsed/refractory setting
COMy 2016 Disease Therapy in Myeloma: Richardson
Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T Therapies
Daratumumab and isatuximab in the treatment of multiple myeloma
